ANTIPHONICS IVS — Credit Rating and Financial Key Figures

CVR number: 35651543
Ørslevvej 4, 2730 Herlev
andreasbrixen@gmail.com

Income statement (kDKK)

2016
2017
2018
2019
2020
Fiscal period length1212121212
Net sales45.3141.0469.8511.2111.73
Costs of manufacturing-8.75-11.97-18.61-8.78-8.34
External services-1.70
Gross profit20.9813.6044.78-5.77-6.79
Costs of management-13.88-15.48-6.46-8.20-10.18
EBIT15.979.3439.95-6.69-7.95
Pre-tax profit15.979.3439.95-6.69-7.95
Income taxes-3.95
Net earnings15.979.3436.01-6.69-7.95

Assets (kDKK)

2016
2017
2018
2019
2020
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Finished products/goods-23.99-32.1241.4033.3825.03
Inventories total-23.99-32.1241.4033.3825.03
Current trade debtors-6.33-0.080.080.080.08
Short term receivables total-6.33-0.080.080.080.08
Cash and bank deposits67.6156.56-27.48106.4198.46
Cash and cash equivalents67.6156.56-27.48106.4198.46
Balance sheet total (assets)37.2824.3714.00139.86123.57

Equity and liabilities (kDKK)

2016
2017
2018
2019
2020
Share capital1.001.001.001.001.00
Retained earnings23.4013.57-23.91144.43129.48
Profit of the financial year15.979.3436.01-6.69-7.95
Shareholders equity total40.3723.9113.10138.74122.53
Non-current liabilities total
Other non-interest bearing current liabilities-3.080.460.901.121.04
Current liabilities total-3.080.460.901.121.04
Balance sheet total (liabilities)37.2824.3714.00139.86123.57
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.